These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 35791792)
1. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort. Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792 [TBL] [Abstract][Full Text] [Related]
2. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography. Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M; J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437 [TBL] [Abstract][Full Text] [Related]
3. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease. Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842 [No Abstract] [Full Text] [Related]
5. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362 [TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262 [TBL] [Abstract][Full Text] [Related]
7. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207 [TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985 [TBL] [Abstract][Full Text] [Related]
9. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone. Duman S; Kuru D; Gumussoy M; Kiremitci S; Gokcan H; Ulas B; Ellik Z; Ozercan M; Er RE; Karakaya F; Bodakci E; Erden A; Elhan AH; Savas B; Loomba R; Idilman R Eur Radiol; 2024 Jun; 34(6):3882-3888. PubMed ID: 37987833 [TBL] [Abstract][Full Text] [Related]
10. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease. Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M; J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635 [TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis. Lefebvre T; Wartelle-Bladou C; Wong P; Sebastiani G; Giard JM; Castel H; Murphy-Lavallée J; Olivié D; Ilinca A; Sylvestre MP; Gilbert G; Gao ZH; Nguyen BN; Cloutier G; Tang A Eur Radiol; 2019 Dec; 29(12):6477-6488. PubMed ID: 31278577 [TBL] [Abstract][Full Text] [Related]
13. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165 [TBL] [Abstract][Full Text] [Related]
14. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study. Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Singh S; Venkatesh SK; Loomba R; Wang Z; Sirlin C; Chen J; Yin M; Miller FH; Low RN; Hassanein T; Godfrey EM; Asbach P; Murad MH; Lomas DJ; Talwalkar JA; Ehman RL Eur Radiol; 2016 May; 26(5):1431-40. PubMed ID: 26314479 [TBL] [Abstract][Full Text] [Related]
16. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172 [TBL] [Abstract][Full Text] [Related]
18. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798 [TBL] [Abstract][Full Text] [Related]
19. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929 [TBL] [Abstract][Full Text] [Related]
20. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]